NIH Grant Funds At-Home VortexPAP Development

The National Institutes of Health has awarded a grant to AcouFlow Therapeutics. This funding supports the next phase for the VortexPAP. It's a novel positive airway pressure device. The goal is to create a user-friendly, at-home version. This will allow for expanded real-world testing.

Currently, the VortexPAP is only used overnight in clinical settings. Trained technicians operate it during sleep studies. The new design is simplified. It aims to let patients use it independently at home.

Aerospace-biomedical engineer Liran Oren, PhD, commented. Oren is a research associate professor at the University of Cincinnati College of Medicine. "It's an important milestone," Oren said. "It leads to our next goal: testing VortexPAP with many people. Testing will be at multiple locations over a longer time."

How VortexPAP Works

The device uses a principle from aerospace engineering. It's called vortex airflow. This flow control mechanism pressurizes the upper airways. It does this without a traditional tight-fitting mask seal. The approach is a collaboration. Experts in aerospace engineering, biomedical engineering, and sleep medicine are involved.

Eliminating the seal allows for a minimalistic interface. The design aims to reduce common CPAP complaints. It targets claustrophobia. It also targets air swallowing. It operates at lower pressures.

The Path to Real-World Testing

The NIH grant will fund required engineering work. This work will adapt the clinical device for home use. The focus is on simplification and user-friendliness. After development, the next step is broader testing.

Future trials will evaluate the device's everyday efficacy. Testing will involve more participants. It will be across multiple locations. It will be over extended periods. This data is crucial. It demonstrates the device's practical benefits outside a lab.

Addressing CPAP Adherence

Poor adherence is a major challenge in sleep apnea therapy. Many patients abandon traditional CPAP machines. They do this due to discomfort. The VortexPAP is designed to tackle this problem.

Its seal-less operation could make therapy more tolerable. It reduces pressure and interface bulk. This may help users stick with their treatment long-term. The project represents an engineering-driven approach. It addresses a persistent clinical issue.

The work is a collaboration. It is between AcouFlow Therapeutics and the University of Cincinnati. The team will now focus on building the at-home prototype. Their progress will be watched closely. The sleep medicine community is eager for innovations. Innovations that improve patient compliance are needed.